View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
In one study, an experimental diagnostic test called molecular breast imaging (MBI) revealed more tumors and gave fewer false positives than mammograms, researchers reported at the American Society of Clinical Oncology conference in Washington, D.C. The test shows promise for detecting cancer in dense breast tissue, which makes tumors harder to find on mammogram. An estimated 25% of women over age 40 have dense breasts.
With MBI, women receive an I.V. dose of a short- acting radioactive tracer that abnormal cells absorb more readily than healthy cells. Gamma cameras detect the telltale glow.
Researchers compared MBI and mammography on 940 women with dense breasts and a high risk of cancer. They found 13 tumors in 12 women. MBI found 10 out of the 13 tumors; mammography only 3. The rate of false positives was 9% for mammography versus 7% for MBI.
One drawback of MBI is that it exposes the patient to 8 to 10 times more radiation than mammography, although researchers are working on ways to reduce the radiation dose. The Mayo Clinic (Rochester, Minn.) is leading a study to evaluate how MBI stacks up against magnetic resonance imaging.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top